Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGTs-BD: Lithium Combinations for Bipolar Depression
NCT01938859Phase 4Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Jun 2012
- Primary completion
- Dec 2017
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso), Shuganjieyu capsule in bipolar disorder (BD), sponsored by Shanghai Mental Health Center. Status: unknown.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)Shuganjieyu capsule
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01938859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938859.